Update - Vitalograph Brexit Statement

30th September 2019

On the 23rd June 2016 the UK voted to leave the EU. Negotiations since then have yet to shed any light on what the final trading arrangements will be between the UK, the EU and the rest of the world. The UK government is committed to leaving with a deal with the departure date now extended to October 2019, however, the current stalemate within parliament means that no deal remains a real possibility.

Due to the on-going uncertainty, we will continue to monitor the situation closely and will update this statement with any further new information to hand.

Vitalograph will continue the Brexit contingency planning initiative, directed by our Business Continuity Planning (BCP) group to identify, address and mitigate potential risks to continuity of the supply of products and services. The ever-changing situation is reviewed on a regular basis and all the main potential risks have been identified and addressed at this stage.

The following actions have been taken to mitigate the impact of Brexit:

  • Full review & re-stock where necessary in our UK and German warehouses to counteract any shipping delays.
  • EORI registration in place to mitigate custom’s issues with import/export between EU and UK sites.
  • Provisions to assign Vitalograph UK as manufacturer’s representative for import to UK.
  • Transfer of notified body from the British Standards Institution (BSI) UK to BSI NL to ensure validity of CE registration post Brexit.
  • We are continually reviewing MHRA guidance for the import of Medical Devices from the EU to UK. Based on current available information we can meet their requirements.

Please note that Vitalograph has business operations located in multiple, diverse countries with critical suppliers multi-sourced from different geographies.

Should any customer require any further detail on our Brexit preparations then please contact brexitplanning@vitalograph.co.uk